Chitosan-based delivery systems for protein therapeutics and antigens

被引:478
作者
Amidi, Maryam [1 ]
Mastrobattista, Enrico [1 ]
Jiskoot, Wim [2 ]
Hennink, Wim E. [1 ]
机构
[1] Univ Utrecht, UIPS, Dept Pharmaceut, NL-3508 TB Utrecht, Netherlands
[2] Leiden Univ, LACDR, Div Drug Delivery Technol, NL-2300 RA Leiden, Netherlands
关键词
Chitosan; Trimethylated chitosan (TMC); Protein/peptides delivery; Mucosal delivery; Targeting; Vaccination; Micro- and nanoparticles; N-TRIMETHYL CHITOSAN; IN-VITRO EVALUATION; BORDETELLA-BRONCHISEPTICA ANTIGENS; NASAL ABSORPTION ENHANCEMENT; BRONCHIAL LYMPHOID-TISSUE; PEPTIDE DRUG-DELIVERY; T-CELL EPITOPES; MOLECULAR-WEIGHT; INTRANASAL IMMUNIZATION; IMMUNE-RESPONSES;
D O I
10.1016/j.addr.2009.11.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Therapeutic peptides/proteins and protein-based antigens are chemically and structurally labile compounds, which are almost exclusively administered by parenteral injections. Recently, non-invasive mucosal routes have attracted interest for administration of these biotherapeutics. Chitosan-based delivery systems enhance the absorption and/or cellular uptake of peptides/proteins across mucosal sites and have immunoadjuvant properties. Chitosan is a mucoadhesive polysaccharide capable of opening the tight junctions between epithelial cells and it has functional groups for chemical modifications, which has resulted in a large variety of chitosan derivatives with tunable properties for the aimed applications. This review provides an overview of chitosan-based polymers for preparation of both therapeutic peptides/protein and antigen formulations. The physicochemical properties of these carrier systems as well as their applications in protein and antigen delivery through parenteral and mucosal (particularly nasal and pulmonary) administrations are summarized and discussed. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:59 / 82
页数:24
相关论文
共 214 条
[1]   Nasal delivery of vaccines [J].
Almeida, AJ ;
Alpar, HO .
JOURNAL OF DRUG TARGETING, 1996, 3 (06) :455-467
[2]   Formation of new glucomannan-chitosan nanoparticles and study of their ability to associate and deliver proteins [J].
Alonso-Sande, Maria ;
Cuna, Margarita ;
Remunan-Lopez, Carmen .
MACROMOLECULES, 2006, 39 (12) :4152-4158
[3]   Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery [J].
Alpar, HO ;
Somavarapu, S ;
Atuah, KN ;
Bramwell, V .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (03) :411-430
[4]   Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system [J].
Amidi, M ;
Romeijn, SG ;
Borchard, G ;
Junginger, HE ;
Hennink, WE ;
Jiskoot, W .
JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) :107-116
[5]   Efficacy of pulmonary insulin delivery in diabetic rats: Use of a model-based approach in the evaluation of insulin powder formulations [J].
Amidi, Maryam ;
Krudys, Kevin M. ;
Snel, Cor J. ;
Crommelin, Daan J. A. ;
Della Pasqua, Oscar E. ;
Hennink, Wim E. ;
Jiskoot, Wim .
JOURNAL OF CONTROLLED RELEASE, 2008, 127 (03) :257-266
[6]   Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery [J].
Amidi, Maryam ;
Pellikaan, Hubert C. ;
de Boer, Anne H. ;
Crommelin, Daan J. A. ;
Hennink, Wim E. ;
Jiskoot, Wim .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 68 (02) :191-200
[7]   Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: Preparation, characterization and evaluation in guinea pigs [J].
Amidi, Maryam ;
Pellikaan, Hubert C. ;
Hirschberg, Hoang ;
de Boerd, Anne H. ;
Crommelin, Daan J. A. ;
Hennink, Wim E. ;
Kersten, Gideon ;
Jiskoot, Wim .
VACCINE, 2007, 25 (37-38) :6818-6829
[8]   N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination:: Biological properties and immunogenicity in a mouse model [J].
Amidi, Maryam ;
Romeijn, Stefan G. ;
Verhoef, J. Coos ;
Junginger, Hans E. ;
Bungener, Laura ;
Huckriede, Anke ;
Crommelin, Daan J. A. ;
Jiskoot, Wim .
VACCINE, 2007, 25 (01) :144-153
[9]   EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2) [J].
ARTURSSON, P ;
LINDMARK, T ;
DAVIS, SS ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1358-1361
[10]   Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform [J].
Baudner, BC ;
Verhoef, JC ;
Giuliani, MM ;
Peppoloni, S ;
Rappuoli, R ;
Del Giudice, G ;
Junginger, HE .
JOURNAL OF DRUG TARGETING, 2005, 13 (8-9) :489-498